[Updates in systemic sclerosis pathogenesis: Toward new therapeutic opportunities].

Area of Science:

• Rheumatology
• Immunology
• Fibrosis Research

Background:

• Systemic sclerosis is a rare connective tissue disease featuring fibrosis, vasculopathy, and immune abnormalities.
• The precise origin and chronological development of systemic sclerosis pathogenesis remain incompletely understood.
• Oxidative stress, influenced by genetic and environmental factors, is implicated in early disease phases.

Purpose of the Study:

• To review recent advancements in understanding systemic sclerosis pathogenesis.
• To explore the implications of new pathogenic insights for current and future medical care.
• To highlight novel therapeutic opportunities arising from a deeper knowledge of the disease.

Main Methods:

• Literature review focusing on recent research in systemic sclerosis.
• Analysis of studies investigating the role of oxidative stress and immune cells.
• Evaluation of current and emerging therapeutic strategies.

Main Results:

• Fibroblast and endothelial cell dysfunction, alongside immune cell involvement, are key features.
• Oxidative stress appears crucial in early fibrosis, vasculopathy, and immune tolerance.
• Autologous hematopoietic stem cell transplantation offers lasting fibrosis regression in severe cases but carries significant toxicity.

Conclusions:

• Recent discoveries have illuminated new mechanisms in systemic sclerosis pathogenesis.
• These insights are paving the way for improved therapeutic strategies.
• Further research into pathogenic pathways is essential for developing effective treatments.